Editorial: Uniformity Before Prediction: The Unfinished Science of Attention-Deficit/Hyperactivity Disorder Forecasting - 14/08/25
Résumé |
A central ambition of medicine—particularly in the realm of chronic and developmental disorders—is not only to diagnose with precision, but also to anticipate the course of illness with foresight and nuance.1 In psychiatry, this has historically been an elusive pursuit. Whereas other specialties have long relied on prognostic models to shape prevention and personalize care, mental health research has only more recently begun to systematically identify predictors of clinical trajectories and long-term outcomes.2
This need is particularly relevant in attention-deficit/hyperactivity disorder (ADHD), a condition with a highly variable course and often underestimated long-term impact. Once dismissed as a self-limited feature of childhood, ADHD is now firmly established as a condition that for many persists into adulthood—reshaping education, employment, relationships, and mental health.3,4 Yet the fundamental clinical question endures: which children with ADHD are most at risk for poor adult outcomes? Also, can we identify early indicators that genuinely alter the course of care?
Le texte complet de cet article est disponible en PDF.Plan
| The author has reported no funding for this work. |
|
| Disclosure: Arthur Caye has served as a consultant for Knight Therapeutics, Libbs, and EMS pharmaceuticals in the last 3 years. |
|
| All statements expressed in this column are those of the authors and do not necessarily reflect the opinions of the Journal of the American Academy of Child and Adolescent Psychiatry. See the Guide for Authors for information about the preparation and submission of Editorials. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?